M&T Bank
ACAD icon

M&T Bank’s Acadia Pharmaceuticals ACAD Stock Holding History

M&T Bank’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-12,218
Closed -$512K – 1809
2015
Q2 		$512K Sell
12,218
-1,110
-8% -$43K ﹤0.01% 1195
2015
Q1 		$435K Sell
13,328
-695
-5% -$23.9K ﹤0.01% 1261
2014
Q4 		$446K Sell
14,023
-3,450
-20% -$97.8K ﹤0.01% 1272
2014
Q3 		$432K Buy
+17,473
New +$409K ﹤0.01% 1338
2014
Q2 		– Sell
-63
Closed -$2K – 1078
2014
Q1 		$2K Buy
+63
New +$1.59K ﹤0.01% 1114

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return